The NIPT Trend

A number of companies now offer non-invasive prenatal tests that can, by isolating fetal DNA from the mother's bloodstream, determine if the fetus has a chromosomal disorder. And, as Fortune's Clay Dillow writes, those tests may soon be able to detect even more disorders. "[I]f parents could know more about their child's health before birth, wouldn't they want to?" he adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Screening Test

This Week in PNAS

Big Pregnancy Data

No Sweating

What Does It Mean?

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.